{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFRL858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper states that EGFR is a key oncogene in non-small cell lung cancer (NSCLC) and that L858R mutation is a well-established activating mutation.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The paper describes an enzyme activity assay to measure EGFR kinase activity, which is relevant to NSCLC.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_step": "3c: Variant Controls",
      "extracted_paper_info": "The paper used L861Q (a known pathogenic variant) and E746_A750del (a known benign variant) as controls.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_step": "4c: Correlate OddsPath",
      "extracted_paper_info": "The paper reports an OddsPath value of 25.6 for EGFRL858R.",
      "judgment": "Yes"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The functional assay demonstrated a strong pathogenic effect for EGFRL858R, with an OddsPath value of 25.6."
}